Substance use & misuse · 2026
Yoga for Tobacco Cessation: A Randomized Controlled Trial (QUIT-SMART).
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lama Sudha, Singh Shruti, Haldar Partha, Shukla Asmita, Chhabra Varun, Shukla Akriti, Vibin Anu James, Singh Jat Man, Dhanlika Dhanlika, Sagar Rajesh, Singh Udisha, Sharma Gautam
Аннотация
BACKGROUND: Current tobacco cessation strategies, including pharmacological interventions and supportive therapies, have limitations related to adherence and relapse. Emerging evidence suggests that yoga plays a significant role in tobacco cessation through psycho-behavioral mechanisms. This study was conducted to evaluate the role of yoga among adults who used both smoking and smokeless forms (SLT) of tobacco.
METHODS: A prospective, randomized, open-label, blinded endpoint trial was conducted among adult tobacco users. Participants were randomly assigned to either the yoga (n = 64) or the exercise (n = 66). The primary outcome was 7-day point prevalence abstinence (7-PPA) validated by salivary cotinine, at 6 months. Secondary outcomes included quality of life (QoL), assessed using WHOQOL-BREF, and psychological health was assessed using DASS-21.
RESULTS: Between December 2021 and June 2023, 910 adult tobacco users were screened. A total of 130 participants (96.9% male) were enrolled, including 51 (39.3%) who used smoking tobacco and 79 (60.7%) who used smokeless tobacco. At 6 months, 14 (22%) participants in the yoga group achieved 7-PPA, compared to 6 (9.1%) in the exercise group (p = 0.043) (OR: 2.8, 95% CI: 1.04-8.40). The yoga group demonstrated greater improvements in QoL (p < 0.05), and psychological health outcomes, including stress and anxiety (p < 0.001) and depression (p = 0.008).
CONCLUSION: Yoga demonstrated a significantly higher rate of 7-PPA compared with exercise. The yoga group also showed greater improvements in QoL and psychological outcomes. These findings suggest that yoga may serve as a feasible complementary intervention for tobacco cessation among adult tobacco users.
TRIAL REGISTRATION: Clinical Trial Registry India number; CTRI/2021/12/038745. Date of Registration - Dec 20, 2021.
METHODS: A prospective, randomized, open-label, blinded endpoint trial was conducted among adult tobacco users. Participants were randomly assigned to either the yoga (n = 64) or the exercise (n = 66). The primary outcome was 7-day point prevalence abstinence (7-PPA) validated by salivary cotinine, at 6 months. Secondary outcomes included quality of life (QoL), assessed using WHOQOL-BREF, and psychological health was assessed using DASS-21.
RESULTS: Between December 2021 and June 2023, 910 adult tobacco users were screened. A total of 130 participants (96.9% male) were enrolled, including 51 (39.3%) who used smoking tobacco and 79 (60.7%) who used smokeless tobacco. At 6 months, 14 (22%) participants in the yoga group achieved 7-PPA, compared to 6 (9.1%) in the exercise group (p = 0.043) (OR: 2.8, 95% CI: 1.04-8.40). The yoga group demonstrated greater improvements in QoL (p < 0.05), and psychological health outcomes, including stress and anxiety (p < 0.001) and depression (p = 0.008).
CONCLUSION: Yoga demonstrated a significantly higher rate of 7-PPA compared with exercise. The yoga group also showed greater improvements in QoL and psychological outcomes. These findings suggest that yoga may serve as a feasible complementary intervention for tobacco cessation among adult tobacco users.
TRIAL REGISTRATION: Clinical Trial Registry India number; CTRI/2021/12/038745. Date of Registration - Dec 20, 2021.